From: Antibiotics for the treatment of Cholera, Shigella and Cryptosporidiumin children
Quality Assessment | Summary of Findings | |||||||
---|---|---|---|---|---|---|---|---|
Ìý | Directness | No of events | Ìý | |||||
No of studies | Design | Limitations | Consistency | Generalizability to population of interest | Generalizability to intervention of interest | Intervention | Control | Relative Risk (95%CI) |
Clinical Failure (Antibiotics): Moderate Outcome Quality | ||||||||
RCT | No Control or placebo group, so used treatment failure rates | All suggest benefit | All studies were conducted in developing countries | Hospital based | 50 | Ìý | 0.18 (0.1, 0.33) b | |
Bacteriological Failure (Antibiotics): Low Outcome Quality | ||||||||
RCT | No Control or placebo group, so used treatment failure rates | All suggest benefit | All studies except one were conducted in developing countries | Hospital based | 09 | Ìý | 0.04 (0.01, 0.12) b |